Review of 336 patients with hepatocellular carcinoma at Songklanagarind Hospital

Table 3 Median survival

Group of patients	n	Median survival (months)
All	336	2.1
Stage I	51	11.5
Stage II	205	2.6
Stage III	80	0.73
Untreated	245	1.6
Stage I	26	7.7
Stage II	146	1.8
Stage III	73	0.63
Treated	91	5.5
Stage I	25	13.7
Stage II	59	4.2
Stage III	7	1.7
TOCE	44	6.3
Stage I	11	24.3
Stage II	29	5.5
Stage III	4	1.4
Chemotherapy (adriamycin and/or 5-FU)	16	5.2
Multimodality therapy	12	17.1
(PIAF/iv, chemotherapy ± TOCE ± PEI)
Tamoxifen	9	3.0
PIAF regimen chemotherapy	5	*
Hepatectomy	4	$
PEI	1	$

^*Data of PIAF regimen chemotherapy is not completely finished. $It were too small number of patients to evaluated.